应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01167 加科思-B
未开盘 05-06 16:08:10
6.330
-0.280
-4.24%
最高
6.630
最低
6.240
成交量
699.81万
今开
6.630
昨收
6.610
日振幅
5.90%
总市值
49.69亿
流通市值
49.69亿
总股本
7.85亿
成交额
4,459万
换手率
0.89%
流通股本
7.85亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
加科思-B:5月6日回购7.29万股股份,总额约46.06万港元
公告速递 · 05-06 18:47
加科思-B:5月6日回购7.29万股股份,总额约46.06万港元
加科思-B(01167)5月6日斥资46.06万港元回购7.29万股
智通财经 · 05-06 18:40
加科思-B(01167)5月6日斥资46.06万港元回购7.29万股
加科思-B:5月5日回购70,500股股份,涉资约47.01万港元
公告速递 · 05-05 17:51
加科思-B:5月5日回购70,500股股份,涉资约47.01万港元
加科思-B(01167)5月4日斥资46.05万港元回购6.75万股
智通财经 · 05-04 20:55
加科思-B(01167)5月4日斥资46.05万港元回购6.75万股
加科思-B:5月4日回购6.75万股,涉资约46.05万港元
公告速递 · 05-04 20:45
加科思-B:5月4日回购6.75万股,涉资约46.05万港元
加科思-B 4月30日回购70,800股股份,耗资约49.98万港元
公告速递 · 04-30
加科思-B 4月30日回购70,800股股份,耗资约49.98万港元
加科思-B回购64,800股股份,涉资约45.89万港元
公告速递 · 04-29
加科思-B回购64,800股股份,涉资约45.89万港元
加科思-B(01167)4月29日耗资约45.89万港元回购6.48万股
智通财经 · 04-29
加科思-B(01167)4月29日耗资约45.89万港元回购6.48万股
加科思-B:4月28日回购6.54万股股份,涉资约46.55万港元
公告速递 · 04-28
加科思-B:4月28日回购6.54万股股份,涉资约46.55万港元
加科思-B(01167)4月27日斥资47.28万港元回购6.6万股
智通财经 · 04-27
加科思-B(01167)4月27日斥资47.28万港元回购6.6万股
加科思-B2025年度:收入53.5百万元,核心管线推进与亏损收窄并行
公告速递 · 04-24
加科思-B2025年度:收入53.5百万元,核心管线推进与亏损收窄并行
加科思-B授予董事股份购回授权,规模达已发行股本一成
公告速递 · 04-24
加科思-B授予董事股份购回授权,规模达已发行股本一成
加科思-B(01167)4月23日耗资约49.45万港元回购6.75万股
智通财经 · 04-24
加科思-B(01167)4月23日耗资约49.45万港元回购6.75万股
加科思-B:4月23日回购6.75万股,涉资约49.45万港元
公告速递 · 04-24
加科思-B:4月23日回购6.75万股,涉资约49.45万港元
加科思-B:4月22日回购6.27万股,耗资约49.12万港元
公告速递 · 04-23
加科思-B:4月22日回购6.27万股,耗资约49.12万港元
加科思-B(01167)4月22日耗资约49.12万港元回购6.27万股
智通财经 · 04-23
加科思-B(01167)4月22日耗资约49.12万港元回购6.27万股
加科思-B:4月21日回购6.39万股,耗资约49.82万港元
公告速递 · 04-21
加科思-B:4月21日回购6.39万股,耗资约49.82万港元
加科思-B(01167)4月21日斥资49.8万港元回购6.39万股
智通财经 · 04-21
加科思-B(01167)4月21日斥资49.8万港元回购6.39万股
加科思-B回购61,500股,耗资约49.91万港元
公告速递 · 04-20
加科思-B回购61,500股,耗资约49.91万港元
加科思-B(01167)4月20日斥资49.9万港元回购6.15万股
智通财经 · 04-20
加科思-B(01167)4月20日斥资49.9万港元回购6.15万股
加载更多
公司概况
公司名称:
加科思-B
所属市场:
SEHK
上市日期:
--
主营业务:
加科思药业集团有限公司是一家主要从事临床阶段新药研发的投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。该公司主要药物开发项目包括JAB-21822及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":6.33,"timestamp":1778054890003,"preClose":6.61,"halted":0,"volume":6998082,"delay":0,"changeRate":-0.042360060514372196,"floatShares":785000000,"shares":785000000,"eps":-0.21674532259328327,"marketStatus":"未开盘","change":-0.28,"latestTime":"05-06 16:08:10","open":6.63,"high":6.63,"low":6.24,"amount":44586950,"amplitude":0.059002,"askPrice":6.33,"askSize":1200,"bidPrice":6.32,"bidSize":3600,"shortable":3,"etf":0,"ttmEps":-0.21674532259328327,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778117400000},"marketStatusCode":0,"adr":0,"listingDate":1608480000000,"exchange":"SEHK","adjPreClose":6.61,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":3.4683248217139373,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167","defaultTab":"news","newsList":[{"id":"1151559409","title":"加科思-B:5月6日回购7.29万股股份,总额约46.06万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151559409","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151559409?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:47","pubTimestamp":1778064420,"startTime":"0","endTime":"0","summary":"加科思-B于2026年5月6日发布公告,披露当日于香港联交所场内回购股份的最新进展。公告日期为2026年5月6日。根据公告,公司于2026年5月6日回购7.29万股普通股,占该次回购前已发行股本约0.00929%。每股回购价格介乎港币6.30元至6.33元,总耗资约46.06万港元。公告显示,公司于2025年6月10日经股东决议通过股份回购授权,授权范围为78,873,528股。公司在公告中确认,上述股份回购符合香港联合交易所有限公司证券上市规则等相关规定。公告由董事王晓洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:5月6日回购7.29万股股份,总额约46.06万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633818198","title":"加科思-B(01167)5月6日斥资46.06万港元回购7.29万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633818198","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633818198?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:40","pubTimestamp":1778064007,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年5月6日,该公司斥资46.06万港元回购7.29万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109516233","title":"加科思-B:5月5日回购70,500股股份,涉资约47.01万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109516233","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109516233?lang=zh_cn&edition=full","pubTime":"2026-05-05 17:51","pubTimestamp":1777974660,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年5月5日回购普通股70,500股,占回购前公司已发行股本的约0.00898%。本次回购在香港联交所场内进行,回购价介乎每股港币6.61至6.68元,合计支付金额约港币47.01万元。完成回购后,公司已发行股本为785,070,480股,库藏股数量为6,684,600股,总股份数为791,755,080股。公司于2025年6月10日通过股份回购授权,授权总数为78,873,528股,截至目前已回购3,664,800股股份,占授权通过当日已发行股本的约0.46464%。本次公告由公司董事王晓洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:5月5日回购70,500股股份,涉资约47.01万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955366","title":"加科思-B(01167)5月4日斥资46.05万港元回购6.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955366","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632955366?lang=zh_cn&edition=full","pubTime":"2026-05-04 20:55","pubTimestamp":1777899314,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年5月4日该公司斥资46.05万港元回购6.75万股,回购价格为每股7.79-7.84港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01167","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198940077","title":"加科思-B:5月4日回购6.75万股,涉资约46.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198940077","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198940077?lang=zh_cn&edition=full","pubTime":"2026-05-04 20:45","pubTimestamp":1777898756,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年5月4日在香港联交所回购股份,根据5月4日发布的公告,本次回购涉及6.75万股普通股,占回购前已发行股本约0.0086%。每股回购价格在7.79港元至7.84港元之间,合计支付约46.05万港元。回购完成后,公司已发行股份数量由785,208,480股降至785,140,980股,库藏股增至6,614,100股。根据购回授权,公司可回购股份总数为78,873,528股,截至公告日已回购合计3,594,300股。公司确认本次股份回购符合香港联交所证券上市规则及相关法律规定。本公告由董事王晓洁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:5月4日回购6.75万股,涉资约46.05万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176766188","title":"加科思-B 4月30日回购70,800股股份,耗资约49.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176766188","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176766188?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:01","pubTimestamp":1777546905,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年4月30日发布公告,披露当日进行了股份购回交易。根据公告,公司于香港联交所场内共回购70,800股普通股,占该公司回购前已发行股本的约0.00902%。每股回购价格介乎7.01港元至7.08港元,合计涉资约49.98万港元。回购完成后,公司已发行股本约为785,208,480股,库藏股数量增至6,546,600股,总发行股份则仍为791,755,080股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"加科思-B 4月30日回购70,800股股份,耗资约49.98万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118764727","title":"加科思-B回购64,800股股份,涉资约45.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118764727","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118764727?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:16","pubTimestamp":1777464968,"startTime":"0","endTime":"0","summary":"加科思-B于2026年4月29日发布公告,披露公司已于同日通过香港联交所场内回购64,800股股份,占该次事件前公司已发行股本的约0.00825%。本次回购每股价格介乎港元7.05至港元7.10,总耗资约45.89万港元。回购完成后,公司已发行股本为785,279,280股,库存股份数量增至6,475,800股。根据公告,在本次回购后至2026年5月29日期间,除获联交所批准外,公司不得进行任何新股发行、出售或转让库存股份,亦不得公布相关发行或出售计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B回购64,800股股份,涉资约45.89万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519110","title":"加科思-B(01167)4月29日耗资约45.89万港元回购6.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631519110?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:15","pubTimestamp":1777464909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,2026年4月29日耗资约45.89万港元回购6.48万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01167","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135247951","title":"加科思-B:4月28日回购6.54万股股份,涉资约46.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135247951","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135247951?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:11","pubTimestamp":1777374715,"startTime":"0","endTime":"0","summary":"加科思-B于2026年4月28日发布公告称,公司于香港联交所场内回购了6.54万股普通股股份,约占回购前已发行股本的0.00833%。回购价格区间介乎每股港币7.09元至7.14元,累计支付总金额约港币46.55万元。购回授权由公司于2025年6月10日通过,授予公司可回购7,887.3528万股股份,截至本次回购后,按该授权累计在证券交易所已回购的股份数为339.12万股。公司方面表示,本次股份回购及相关程序均符合香港联交所证券上市规则和相关法例的规定。公告由董事王晓洁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:4月28日回购6.54万股股份,涉资约46.55万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630970093","title":"加科思-B(01167)4月27日斥资47.28万港元回购6.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630970093","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630970093?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:08","pubTimestamp":1777298933,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年4月27日,该公司斥资47.28万港元回购6.6万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175016451","title":"加科思-B2025年度:收入53.5百万元,核心管线推进与亏损收窄并行","url":"https://stock-news.laohu8.com/highlight/detail?id=1175016451","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175016451?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:46","pubTimestamp":1777020376,"startTime":"0","endTime":"0","summary":"加科思-B于2025年度实现收入53.5百万元人民币,较上一年度的155.7百万元显著减少,主要源于对外许可协议收入的波动。报告期内,研发开支从上年度的330.2百万元降至188.6百万元,呈现约42.9%的降幅;行政开支也相应减少至34.4百万元。经营层面,年内亏损由上一年度的155.7百万元收窄至146.0百万元,管理层将其归因于成本控制与若干管线外部合作的持续推进。财务状况方面,截至2025年末,公司资产总值约为1,304.3百万元,非流动资产与流动资产均小幅下滑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"加科思-B2025年度:收入53.5百万元,核心管线推进与亏损收窄并行","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131896569","title":"加科思-B授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1131896569","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131896569?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:43","pubTimestamp":1777020201,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于日前披露公告,计划在股东周年大会上寻求批准一项股份购回授权。公告显示,截至最后可行日期,公司已发行股份总数为785,731,080股。董事会认为,这项举措可为股东带来潜在回报,并视公司财务状况与市况开展。董事会认为,本次购回计划符合公司及股东整体最佳利益,将持续关注市场情况灵活决策。董事会表示,若上述决议获通过,授权有效期将持续至下一届股东周年大会结束或依据相关法规要求被撤销或修订为止。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B授予董事股份购回授权,规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027869","title":"加科思-B(01167)4月23日耗资约49.45万港元回购6.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027869","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629027869?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:16","pubTimestamp":1776982602,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)公布,2026年4月23日耗资约49.45万港元回购6.75万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01167","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179355631","title":"加科思-B:4月23日回购6.75万股,涉资约49.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179355631","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179355631?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:11","pubTimestamp":1776982308,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年4月23日发布公告,披露当日回购股份事宜。根据公告,公司于香港联交所场内回购67,500股普通股,相当于公司已发行股本约0.00859%,每股回购价格介乎每股7.29港元至7.36港元,总涉资约49.45万港元。此次回购后,公司已发行股本为785,475,480股,库藏股数量增至6,279,600股。公司确认,此次回购严格遵守香港联交所上市规则及相关法律程序。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"加科思-B:4月23日回购6.75万股,涉资约49.45万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158617300","title":"加科思-B:4月22日回购6.27万股,耗资约49.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158617300","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158617300?lang=zh_cn&edition=full","pubTime":"2026-04-23 06:16","pubTimestamp":1776896169,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司(股票代码:01167)于2026年4月22日披露回购公告,称当日回购62,700股普通股股份,约占公司现有已发行股本的0.00798%。本次回购每股价格介乎7.80港元至7.85港元,总耗资约49.12万港元。\n回购完成后,公司已发行股本变更为785,542,980股,库藏股数增至6,212,100股。公司表示,此次回购授权系于2025年6月10日获通过,当前剩余可回购股份数为78,873,528股。公司确认已遵守香港联交所上市规则及相关法规。\n公告由董事王晓洁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:4月22日回购6.27万股,耗资约49.12万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629160076","title":"加科思-B(01167)4月22日耗资约49.12万港元回购6.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629160076","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629160076?lang=zh_cn&edition=full","pubTime":"2026-04-23 06:15","pubTimestamp":1776896104,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)公布,2026年4月22日耗资约49.12万港元回购6.27万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142325535","title":"加科思-B:4月21日回购6.39万股,耗资约49.82万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142325535","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142325535?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:31","pubTimestamp":1776781866,"startTime":"0","endTime":"0","summary":"加科思藥業集團有限公司于2026年4月21日发布公告,披露当日进行股份购回交易。公告显示,公司于2026年4月21日在香港联交所场内回购63,900股普通股,占公司已发行股本约0.00813%,每股回购价介乎7.79港元至7.80港元,总涉资约49.82万港元。公司购回授权决议于2025年6月10日获通过,授权总数为78,873,528股。截至公告日,基于该授权已累计回购3,129,600股。公司确认,上述回购行为符合香港联交所上市规则及相关法律法规的要求。本公告由董事王晓洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B:4月21日回购6.39万股,耗资约49.82万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030786","title":"加科思-B(01167)4月21日斥资49.8万港元回购6.39万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030786","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629030786?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:28","pubTimestamp":1776781688,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年4月21日斥资49.8万港元回购6.39万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180550581","title":"加科思-B回购61,500股,耗资约49.91万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180550581","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180550581?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:12","pubTimestamp":1776683558,"startTime":"0","endTime":"0","summary":"加科思-B于2026年4月20日发布翌日披露报表,公告当日通过香港联交所场内回购股份61,500股,约占公司现有已发行股本的0.00783%。每股回购价格介乎8.11港元至8.12港元,总金额约49.91万港元。该回购基于2025年6月10日通过的股份购回授权,公司已根据该授权在市场累计回购3,065,700股,占授权通过当日已发行股份总数的约0.38869%。公司确认本次回购遵守香港联交所主板上市规则等相关法律及程序规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742185","title":"加科思-B(01167)4月20日斥资49.9万港元回购6.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742185","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628742185?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:08","pubTimestamp":1776683293,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年4月20日斥资49.9万港元回购6.15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1021},{"period":"1month","weight":-0.1208},{"period":"3month","weight":0.1086},{"period":"6month","weight":-0.0262},{"period":"1year","weight":0.6357},{"period":"ytd","weight":-0.0063}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0437},{"period":"3month","weight":-0.025},{"period":"6month","weight":-0.0011},{"period":"1year","weight":0.1567},{"period":"ytd","weight":0.0228}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。该公司主要药物开发项目包括JAB-21822及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.0037},{"month":2,"riseRate":0.5,"avgChangeRate":0.158834},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004688},{"month":4,"riseRate":0.666667,"avgChangeRate":0.034456},{"month":5,"riseRate":0.333333,"avgChangeRate":0.039065},{"month":6,"riseRate":0,"avgChangeRate":-0.081428},{"month":7,"riseRate":0.4,"avgChangeRate":0.073857},{"month":8,"riseRate":0.2,"avgChangeRate":0.005746},{"month":9,"riseRate":0.6,"avgChangeRate":-0.002238},{"month":10,"riseRate":0.2,"avgChangeRate":-0.065405},{"month":11,"riseRate":0.4,"avgChangeRate":0.020921},{"month":12,"riseRate":0.2,"avgChangeRate":-0.06824}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}